Hoth Therapeutics, Inc. (HOTH)
HOTH Stock Price Chart
Explore Hoth Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze HOTH price movements and trends.
HOTH Company Profile
Discover essential business fundamentals and corporate details for Hoth Therapeutics, Inc. (HOTH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 Feb 2019
Employees
6.00
Website
https://www.hoththerapeutics.comCEO
Robb Knie
Description
Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
HOTH Financial Timeline
Browse a chronological timeline of Hoth Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 2 Sept 2026
EPS estimate is -$0.14.
Earnings released on 15 May 2026
EPS came in at -$0.17 falling short of the estimated -$0.14 by -23.37%.
Earnings released on 27 Mar 2026
EPS came in at -$0.16 falling short of the estimated -$0.10 by -55.19%.
Earnings released on 12 Nov 2025
EPS came in at -$0.30 matching the estimated -$0.30.
Earnings released on 12 Aug 2025
EPS came in at -$0.17 surpassing the estimated -$0.27 by +37.04%.
Earnings released on 12 May 2025
EPS came in at -$0.27 surpassing the estimated -$0.34 by +20.59%.
Earnings released on 28 Mar 2025
EPS came in at -$0.32 surpassing the estimated -$0.39 by +17.95%.
Earnings released on 12 Nov 2024
EPS came in at -$0.31 falling short of the estimated -$0.30 by -3.33%.
Earnings released on 9 Aug 2024
EPS came in at -$0.24 surpassing the estimated -$0.39 by +38.46%.
Earnings released on 14 May 2024
EPS came in at -$0.46 falling short of the estimated -$0.43 by -6.98%.
Earnings released on 28 Mar 2024
EPS came in at -$0.31 surpassing the estimated -$0.51 by +39.22%, while revenue for the quarter reached $59.54k .
Earnings released on 13 Nov 2023
EPS came in at -$0.60 surpassing the estimated -$0.72 by +16.67%.
Earnings released on 11 Aug 2023
EPS came in at -$0.57 surpassing the estimated -$1.16 by +50.86%.
Earnings released on 15 May 2023
EPS came in at -$0.88 falling short of the estimated -$0.86 by -2.33%.
Earnings released on 31 Mar 2023
EPS came in at -$2.72 falling short of the estimated -$2.29 by -18.78%.
Earnings released on 10 Nov 2022
EPS came in at -$2.05 surpassing the estimated -$2.39 by +14.23%.
Stock split effective on 26 Oct 2022
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Aug 2022
EPS came in at -$2.25 matching the estimated -$2.25.
Earnings released on 12 May 2022
EPS came in at -$2.75 matching the estimated -$2.75.
Earnings released on 30 Mar 2022
EPS came in at -$3.50 falling short of the estimated -$3.00 by -16.67%.
Earnings released on 10 Nov 2021
EPS came in at -$3.50 surpassing the estimated -$3.75 by +6.67%.
Earnings released on 11 Aug 2021
EPS came in at -$3.50 surpassing the estimated -$4.50 by +22.22%.
HOTH Stock Performance
Access detailed HOTH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
